Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1092, 2006-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab: First report of posterior leukoencephalopathy syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1092, 2006-01 ,pp. :
Access to resources
Recommend
Bevacizumab: Reversible posterior leukoencephalopathy syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. :
Bevacizumab: Reversible posterior leukoencephalopathy syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1264, 2009-01 ,pp. :
Bevacizumab: Reversible posterior leukoencephalopathy syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1381, 2011-01 ,pp. :
Bevacizumab/doxorubicin liposomal: Reversible posterior leukoencephalopathy syndrome: case report
Reactions Weekly, Vol. 1, Iss. 1191, 2008-01 ,pp. :